Vitamin D and COVID-19: A Review on the Role of Vitamin D in Preventing and Reducing the Severity of COVID-19 Infection.

Abdrabbo, Mobeen; Birch, Cole M; Brandt, Michael; Cicigoi, Kelsey A; Coffey, Stephen J; Dolan, Connor C; Dvorak, Hannah; Gehrke, Ava C; Gerzema, Audrey E L; Hansen, Abby; Henseler, Ethan J; Huelsbeck, Alyssa C; LaBerge, Ben; Leavens, Caterra M; Le, Christine N; Lindquist, Allison C; Ludwig, Rickaela K; Reynolds, Jacob H; Severson, Nathaniel J; Sherman, Brandon A; Sillman, Hunter W; Smith, Michael A; Smith, Macey A; Snortheim, Marissa J; Svaren, Levi M; Vanderpas, Emily C; Wackett, Miles J; Wozney, Alec J; Bhattacharyya, Sudeep; Hati, Sanchita

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a pathogenic coronavirus causing COVID-19 infection. The interaction between the SARS-CoV-2 spike protein and the human receptor angiotensin-converting enzyme 2, both of which contain several cysteine residues, is impacted by the disulfide-thiol balance in the host cell. The host cell redox status is affected by oxidative stress due to the imbalance between the reactive oxygen/nitrogen species and antioxidants. Recent studies have shown that Vitamin D supplementation could reduce oxidative stress. It has also been proposed that vitamin D at physiological concentration has preventive effects on many viral infections, including COVID-19. However, the molecular-level picture of the interplay of vitamin D deficiency, oxidative stress, and the severity of COVID-19 has remained unclear. Herein, we present a thorough review focusing on the possible molecular mechanism by which vitamin D could alter host cell redox status and block viral entry, thereby preventing COVID-19 infection or reducing the severity of the disease. This article is protected by copyright. All rights reserved.